Atlas Trials

Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality

Clinical trial NCT03746054 · TERMINATED

Trial details

NCT number
NCT03746054
Sponsor
University Hospital, Angers
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia (CML)
Start date
2019-12-20
Primary completion
2024-04-16
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.